PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW124592 |
Ubiquinone and other terpenoid-quinone biosynthesisCannabis sativa
|
Creator: Eponine Oler Created On: March 19, 2021 at 13:05 Last Updated: March 19, 2021 at 13:05 |
PW124158 |
Ubiquinone and other terpenoid-quinone biosynthesisArabidopsis thaliana
|
Creator: Dorsa Yahya Created On: September 13, 2020 at 14:37 Last Updated: September 13, 2020 at 14:37 |
PW126404 |
signaling
Ubiquinone and other terpenoid-quinone biosynthesis 1636480163Cannabis sativa
|
Creator: Guest: Anonymous Created On: November 09, 2021 at 10:49 Last Updated: November 09, 2021 at 10:49 |
PW126979 |
Ubiquinone and other terpenoid-quinone biosynthesis 1636480163Arabidopsis thaliana
|
Creator: Guest: Anonymous Created On: June 04, 2022 at 00:40 Last Updated: June 04, 2022 at 00:40 |
PW126908 |
Ubiquinone and other terpenoid-quinone biosynthesis 1636480163 1652153943Cannabis sativa
|
Creator: Guest: Anonymous Created On: May 09, 2022 at 21:38 Last Updated: May 09, 2022 at 21:38 |
PW126990 |
Ubiquinone and other terpenoid-quinone biosynthesis 1636480163 1652153943 1654630630Cannabis sativa
|
Creator: Guest: Anonymous Created On: June 07, 2022 at 13:37 Last Updated: June 07, 2022 at 13:37 |
PW126948 |
signaling
Ubiquinone and other terpenoid-quinone biosynthesis 1636480163 1653417208Cannabis sativa
|
Creator: Guest: Anonymous Created On: May 24, 2022 at 12:34 Last Updated: May 24, 2022 at 12:34 |
PW122243 |
disease
AspartylglucosaminuriaHomo sapiens
Aspartylglucosaminuria (AGU) is an inherited disease that is characterized by a decline in mental functioning, accompanied by an increase in skin, bone and joint issues. The disease is caused by a defect in an enzyme known as aspartylglucosaminidase (normally present in the liver and brain as well as other tissues). This enzyme plays a significant role in our bodies because it aids in breaking down certain sugars (for example, oligosaccharides) that are attached to specific proteins (for example, glycoproteins). Aspartylglucosaminuria itself is characterized as a lysosomal disease because it does deal with inadequate activity in an enzyme's function. Aspartylglucosaminidase functions to break down glycoproteins. These proteins are most abundant in the tissues of the body and in the surfaces of major organs, such as the liver, spleen, thyroid and nerves. When glycoproteins are not broken down, aspartylglucosaminidase backs up in the lysosomes along with other substances. This backup causes progressive damage to the tissues and organs. Aspartylglucosaminuria is a genetic condition that is inherited from both parents. The AGU patient is born with two copies of the mutated AGA gene. One copy comes from the mother’s egg and the other copy comes from the father’s sperm. In order to develop aspartylglucosaminuria, the individual must inherit changes in both of his AGU genes (autonomic recessive inheritance). When a person receives one changed form of the gene AGU from one of the parents, the individual is then classified as a carrier [Wikipedia].
|
Creator: xuan cao Created On: October 01, 2018 at 11:15 Last Updated: October 01, 2018 at 11:15 |
PW124252 |
biosynthesis novoHomo sapiens
|
Creator: Guest: Anonymous Created On: October 19, 2020 at 17:50 Last Updated: October 19, 2020 at 17:50 |
PW124344 |
biosynthesis novo 1605518331Homo sapiens
|
Creator: Guest: Anonymous Created On: November 16, 2020 at 02:19 Last Updated: November 16, 2020 at 02:19 |